U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}
structurally diverse
Status:
US Approved Rx (2015)
Source:
BLA125510
(2015)
Source URL:
First approved in 2015
Source:
BLA125510
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2015)
Source:
BLA125510
(2015)
Source URL:
First approved in 2015
Source:
BLA125510
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2016)
Source:
BLA125285
(2016)
Source URL:
First approved in 2007
Source:
BLA125254
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2012)
Source:
BLA125020
(2012)
Source URL:
First approved in 1998
Source:
FLUVIRIN by SEQIRUS VACCINES LIMITED
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2014)
Source:
BLA103914
(2014)
Source URL:
First approved in 1998
Source:
FLUVIRIN by SEQIRUS VACCINES LIMITED
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (1996)
Source:
BLA103606
(1996)
Source URL:
First approved in 1995
Source:
BLA103475
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT04449484: Phase 1 Interventional Completed Parkinson's Disease
(2020)
Source URL:

Class:
STRUCTURALLY DIVERSE